Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
Aleksei Titov, Aygul Valiullina, Ekaterina Zmievskaya, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 125-125
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Molecular targeting therapies for neuroblastoma: Progress and challenges
Atif Zafar, Wei Wang, Gang Liu, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 961-1021
Open Access | Times Cited: 254
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
Antonio Passaro, Julie R. Brahmer, Scott Antonia, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 6, pp. 598-610
Closed Access | Times Cited: 184
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 75
Challenges in neoantigen-directed therapeutics
Lien Lybaert, Steve Lefever, Bruno Fant, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 15-40
Open Access | Times Cited: 73
Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold
Kento Fujiwara, Ayaka Tsunei, Hotaka Kusabuka, et al.
Cells (2020) Vol. 9, Iss. 5, pp. 1182-1182
Open Access | Times Cited: 126
Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC): current status and future perspectives
Jingjing Qu, Quanhui Mei, Lijun Chen, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 3, pp. 619-631
Open Access | Times Cited: 112
Mouse Tumor Models for Advanced Cancer Immunotherapy
Daria S. Chulpanova, Kristina V. Kitaeva, Catrin S. Rutland, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4118-4118
Open Access | Times Cited: 104
Advances in PSMA-targeted therapy for prostate cancer
Fujin Wang, Li Z, Xiaoqian Feng, et al.
Prostate Cancer and Prostatic Diseases (2021) Vol. 25, Iss. 1, pp. 11-26
Closed Access | Times Cited: 92
Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast Cancer
Sundee Dees, Rajkumar Ganesan, Sanjaya Singh, et al.
Molecular Cancer Therapeutics (2020) Vol. 19, Iss. 12, pp. 2409-2421
Open Access | Times Cited: 91
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
Ekaterina Zmievskaya, Aygul Valiullina, Irina Ganeeva, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 59-59
Open Access | Times Cited: 84
The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
Niels Schaft
Cancers (2020) Vol. 12, Iss. 9, pp. 2567-2567
Open Access | Times Cited: 82
Adoptive Immunotherapy beyond CAR T-Cells
Aleksei Titov, Ekaterina Zmievskaya, Irina Ganeeva, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 743-743
Open Access | Times Cited: 78
Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
Isabella Monia Montagner, Alessandro Penna, Giulio Fracasso, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1382-1382
Open Access | Times Cited: 69
Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
Tae Jin Kim, Kyo Chul Koo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5484-5484
Open Access | Times Cited: 59
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
Nuphar Veiga, Yael Diesendruck, Dan Peer
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 364-376
Closed Access | Times Cited: 56
Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
Ulrich Hacker, Martin Bentler, Dorota Kaniowska, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1889-1889
Open Access | Times Cited: 56
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e92-e92
Open Access | Times Cited: 34
PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
Marcus Unterrainer, Michael Ruzicka, Matthias P. Fabritius, et al.
European Radiology Experimental (2020) Vol. 4, Iss. 1
Open Access | Times Cited: 48
Current Trends in Cancer Immunotherapy
Ivan Y. Filin, Valeriya V. Solovyeva, Kristina V. Kitaeva, et al.
Biomedicines (2020) Vol. 8, Iss. 12, pp. 621-621
Open Access | Times Cited: 43
Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Vitaly Chasov, Mikhail M. Zaripov, Regina Mirgayazova, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
Temperature- and pH-responsive injectable chitosan hydrogels loaded with doxorubicin and curcumin as long-lasting release platforms for the treatment of solid tumors
Na Li, Jianjun Lin, Chunping Liu, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 23
Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer
Hany E. Marei, Khaled Bedair, Anwarul Hasan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Tumor-Associated Extracellular Matrix Obstacles for CAR-T Cell Therapy: Approaches to Overcoming
Ilya Klabukov, Alexander E. Kabakov, A. O. Yakimova, et al.
Current Oncology (2025) Vol. 32, Iss. 2, pp. 79-79
Open Access
Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
Vitaly Chasov, Regina Mirgayazova, Ekaterina Zmievskaya, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 36
Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
Mohd. Iqbal Yatoo, Zeenat Hamid, IZHAR AHMAD RATHER, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 7, pp. 1897-1909
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top